Skip to content

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00596180
Enrollment
40
Registered
2008-01-16
Start date
2007-01-31
Completion date
2019-12-31
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropsychiatric Sequelae of Carbon Monoxide Poisoning

Keywords

carbon monoxide poisoning, brain injury

Brief summary

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Detailed description

The study is a retrospective review of the PI's experience using SPECT brain imaging and hyperbaric oxygen therapy in the diagnosis and treatment of non-acute phases of carbon monoxide poisoning. The purpose is to see if the SPECT brain imaging is consistent with the clinical condition and cognitive testing on the patients.

Interventions

DRUGHBOT

total body exposure to greater than atmospheric pressure oxygen

Sponsors

Harch Hyperbaric Research Foundation
CollaboratorOTHER
Paul G. Harch, M.D.
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frame
SPECT brain imagingafter completion of HBOT

Secondary

MeasureTime frameDescription
clinical history and physical examafter completion of HBOT
Neuropsychological testingAfter the final HBOTNeuropsychological testing performed after the final HBOT in those who had neuropsychological testing before HBOT

Countries

United States

Contacts

Primary ContactPaul G Harch, M.D.
paulharchmd@gmail.com504-309-4948

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026